Long-Term Management and Living with PH

Because Pemphigus Herpetiformis (PH) is a chronic condition, reaching the end of your initial treatment is not the end of the journey—it is the beginning of the “long-term management” phase. Managing PH over the long term requires a partnership with your medical team to stay ahead of the disease and protect your overall health from the side effects of your medications ^[1][2].

Crucial Safety Warning: Never stop, skip, or rapidly taper prednisone or other systemic immunosuppressants without medical supervision. Doing so is highly dangerous.

Navigating the Risk of Relapse

One of the most important things to understand about PH is that it often follows a “relapsing-remitting” path. In one cohort study of PH patients, 64% of people experienced a relapse at some point after their initial treatment ^[1].

A relapse is not a failure of treatment; it is simply a sign that the immune system has become active again ^[1]. For many, the first sign of a relapse is not a blister, but a return of the intense itching that defined the disease at the start ^[1]. Because the course of PH can be long—sometimes lasting years—consistent follow-up is the best way to catch these flares early and adjust your medications before widespread blistering occurs ^[3][4].

Monitoring for Treatment Side Effects

While medications like prednisone are lifesaving, their long-term use can lead to iatrogenic complications—meaning medical issues caused by the treatment itself. Research shows that a significant number of PH patients develop complications related to their therapy ^[1].

A practical monitoring summary includes:

• Bone Health: Chronic steroids can lead to osteoporosis (thinning of the bones). Your doctor may order a DEXA scan to check your fracture risk and may recommend bone protection like calcium or vitamin D ^[2].
• Metabolic Health: Steroids can increase your blood sugar and your blood pressure ^[2]. Regular blood tests for glucose and blood pressure checks are standard.
• Infection Risk: Cutaneous infections can occur while on treatment ^[1]. Any new redness, warmth, or pus at a blister site should be reported immediately. Vaccine planning should be discussed.
• Organ Monitoring: If taking dapsone or azathioprine, you will need regular blood work (CBC/liver tests and TPMT/NUDT15 considerations). Mycophenolate requires pregnancy precautions and CBC/liver checks ^[2].

Tracking Your Progress Objectively

To take the guesswork out of your care, doctors use standardized scoring tools alongside your symptoms to track how active your disease is.

• PDAI (Pemphigus Disease Area Index): This is a validated activity measure. It scores the extent of disease on the skin, mucosal areas, and scalp. A score of 0 means there is no active disease at that assessment (though true remission terminology also depends on treatment status) ^[5][6][7].
• ABSIS (Autoimmune Bullous Skin Disorder Intensity Score): This tool measures skin involvement and how much your symptoms interfere with daily life ^[6].

While these scores were originally designed for other types of pemphigus, they are valuable in PH to show whether your treatment is working over time ^[8][9].

Living with a Chronic Condition

Living with PH is about more than just skin. The long-term management phase is a balance of vigilance and returning to normal life. Skin involvement is typical and mucosal involvement is less common, but any mouth, eye, swallowing, voice, or breathing symptom should be reported promptly. Many patients can lead very active lives once the itching is controlled ^[1]. Your goal is clinical control: a state where existing blisters heal and no new ones appear, allowing you to gradually lower your medication doses to the safest possible level ^[7].